山东未名生物医药：对外担保管理办法审议通过

Core Viewpoint - Shandong Weiming Bio-Pharmaceutical Co., Ltd. has approved a new external guarantee management approach to regulate the provision of guarantees by the company and its subsidiaries [1][2] Group 1: Definition and Management of External Guarantees - The management approach defines external guarantees as actions taken by the company and its subsidiaries to provide guarantees on behalf of third parties, including loan guarantees, bank acceptance bill guarantees, and letter of guarantee issuance [1] - External guarantees will be managed uniformly, requiring board or shareholder meeting approval for any related legal documents to be signed in the company's name [1] Group 2: Decision-Making Procedures - External guarantees must be reviewed by the board or shareholder meeting, requiring approval from more than half of all directors and a resolution from at least two-thirds of the attending directors [1] - For guarantees exceeding 10% of the company's most recent audited net assets, additional approval from the shareholder meeting is required after board approval [1] Group 3: Approval Process and Responsibilities - The guarantor must submit various credit status documents, which will be verified by the company's financial center and reviewed by relevant departments before being reported to the board [1] - The board is responsible for thoroughly reviewing the situation of the guaranteed party and may hire external professionals to assess risks if necessary [1][2] Group 4: Contractual and Disclosure Obligations - External guarantee contracts must be in writing and include multiple clauses, with the company required to monitor the guaranteed party's situation continuously [2] - The company must enforce debt repayment obligations and initiate counter-guarantee recovery procedures or other risk control measures in specific situations [2] - Strict compliance with information disclosure regulations is mandated, and relevant personnel are bound by confidentiality obligations [2]